Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow

Abstract Background Plasmodium vivax malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for P. vivax, has been reported in the country and has potential to undermine local control efforts. Methods Patients over 6 years of age with uncomp...

Full description

Bibliographic Details
Main Authors: Myo Win Htun, Nan Cho Nwe Mon, Khin Myo Aye, Chan Myae Hlaing, Myat Phone Kyaw, Irene Handayuni, Hidayat Trimarsanto, Dorina Bustos, Pascal Ringwald, Ric N. Price, Sarah Auburn, Kamala Thriemer
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Malaria Journal
Subjects:
Malaria
Plasmodium
Vivax
Chloroquine
Efficacy
Resistance
Online Access:http://link.springer.com/article/10.1186/s12936-017-1912-y

Internet

http://link.springer.com/article/10.1186/s12936-017-1912-y

Similar Items